Patient

P2B-101

withdrawn Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Health Centre Oncology Department (Budapest, Hungary) (Dr. Clarke)

consented 2013-04-17

State Health Centre Oncology Department (Budapest, Hungary)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

mild assessed 2013-06-02

Grade 1 neutropenia with onset in cycle 2 (2013-06-02); assessed as related to study drug (probable); resolved 2013-06-11.

moderate assessed 2013-05-21

Grade 2 alopecia with onset in cycle 1 (2013-05-21); assessed as related to study drug (probable); not resolved at last follow-up.

severe assessed 2013-05-13

Grade 3 leukopenia with onset in cycle 1 (2013-05-13); assessed as related to study drug (probable); resolved 2013-05-19; action: drug interrupted.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users